AI Analysis AI Analysis of OCGN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add OCGN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Ocugen stock price ended at $1.21 on Friday, after losing 0.82%
(Updated on Jun 12, 2026)

Sell candidate since Apr 29, 2026 Loss -27.98%

The Ocugen stock price fell by -0.82% on the last day (Friday, 12th Jun 2026) from $1.22 to $1.21. During the last trading day the stock fluctuated 3.73% from a day low at $1.21 to a day high of $1.25. The price has fallen in 8 of the last 10 days and is down by -12.32% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 4 million shares were bought and sold for approximately $4.48 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.16 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -40.42% during the next 3 months and, with a 90% probability hold a price between $0.690 and $0.88 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

OCGN Signals & Forecast

There are mixed signals in the stock today. The Ocugen stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.25 and $1.44. A break-up above any of these levels will issue buy signals. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 1.68%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Ocugen stock

Ocugen finds support from accumulated volume at $1.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0450 between high and low, or 3.73%. For the last week, the stock has had daily average volatility of 5.73%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (OCGN) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Ocugen Inc to open at $1.22, and during the day (based on 14 day Average True Range), to move between $1.17 and $1.25, which gives a possible trading interval of +/-$0.0793 (+/-6.77%) up or down from last closing price. If Ocugen Inc takes out the full calculated possible swing range there will be an estimated 6.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.19 (1.65%) than the resistance at $1.34 (10.74%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ocugen Inc stock A Buy?

Ocugen holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.217 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $1.22 ( 0.96%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

OCGN Performance

Trading levels for OCGN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.27 4.68%
R2 1.25 3.26%
R1 1.24 2.38%
Price 1.21
S1 1.20 -0.456%
S2 1.19 -1.33%
S3 1.18 -2.75%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.49 23.14%
R2 1.38 14.05%
R1 1.34 10.74%
Price 1.21
S1 1.19 -1.65%
S2 0 -
S3 0 -

FAQ

What is the symbol for Ocugen Stock and on which exchange is it traded?
The symbol for Ocugen is OCGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ocugen Stock?
Ocugen holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Ocugen Stock?
Ocugen Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ocugen Stock.

What's the current price of Ocugen Stock?
As of the end of day on the Jun 12, 2026, the price of an Ocugen (OCGN) share was $1.21.

What is the 52-week high and low for Ocugen Stock?
The 52-week high for Ocugen Stock is $2.73 and the 52-week low is $0.91.

What is the market capitalization of Ocugen Stock?
As of the Jun 12, 2026, the market capitalization of Ocugen is 409.611M.

When is the next earnings date for Ocugen?
The upcoming earnings date for Ocugen is Jul 30, 2026.
Click to get the best stock tips daily for free!
ABOUT OCUGEN INC
Ocugen
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related ...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE